These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18397579)

  • 1. Determination of fentanyl in sweat and hair of a patient using transdermal patches.
    Schneider S; Ait-M-Bark Z; Schummer C; Lemmer P; Yegles M; Appenzeller B; Wennig R
    J Anal Toxicol; 2008 Apr; 32(3):260-4. PubMed ID: 18397579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients.
    Solassol I; Bressolle F; Caumette L; Garcia F; Poujol S; Culine S; Pinguet F
    Ther Drug Monit; 2005 Aug; 27(4):491-8. PubMed ID: 16044107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
    Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
    Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems.
    Coopman V; Cordonnier J; Pien K; Van Varenbergh D
    Forensic Sci Int; 2007 Jul; 169(2-3):223-7. PubMed ID: 16650707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid, simple and sensitive method for the determination and bioequivalence study of transdermal fentanyl in human plasma using liquid chromatography-electrospray ionization tandem mass spectrometry.
    Cheng SQ; Ouyang DS; Tang YJ; Wu K; Xiao J
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):144-56. PubMed ID: 26754304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.
    Hair PI; Keating GM; McKeage K
    Drugs; 2008; 68(14):2001-9. PubMed ID: 18778121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.
    Grond S; Radbruch L; Lehmann KA
    Clin Pharmacokinet; 2000 Jan; 38(1):59-89. PubMed ID: 10668859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the use of a transdermal fentanyl patch in cats.
    Scherk-Nixon M
    J Am Anim Hosp Assoc; 1996; 32(1):19-24. PubMed ID: 8963731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
    Jeal W; Benfield P
    Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat.
    Ashburn MA; Ogden LL; Zhang J; Love G; Basta SV
    J Pain; 2003 Aug; 4(6):291-7. PubMed ID: 14622685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Analgesic Patches in Cynomolgus Macaques (
    Smith AA; Halliday LC; Lindeblad MO; Fortman JD
    J Am Assoc Lab Anim Sci; 2019 May; 58(3):356-361. PubMed ID: 31010456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases.
    Anderson DT; Muto JJ
    J Anal Toxicol; 2000 Oct; 24(7):627-34. PubMed ID: 11043670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.
    Friesen KJ; Woelk C; Bugden S
    CMAJ; 2016 Jun; 188(9):648-653. PubMed ID: 27044480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl transdermal analgesia during pregnancy and lactation.
    Cohen RS
    J Hum Lact; 2009 Aug; 25(3):359-61. PubMed ID: 19286842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal fentanyl combined with nonsteroidal anti-inflammatory drugs for analgesia in horses.
    Thomasy SM; Slovis N; Maxwell LK; Kollias-Baker C
    J Vet Intern Med; 2004; 18(4):550-4. PubMed ID: 15320597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal therapeutic fentanyl-system (TTS-F).
    Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
    In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive absorption of fentanyl from the fentanyl HCl iontophoretic transdermal system.
    Sathyan G; Phipps B; Gupta SK
    Curr Med Res Opin; 2009 Feb; 25(2):363-6. PubMed ID: 19192980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.